Advertisement
Screener

SKYSTAR BIO-PHARMACEUTICAL CO Cash, Period Increase (Decrease)

SKYSTAR BIO-PHARMACEUTICAL CO Cash, Period Increase (Decrease)

SKYSTAR BIO-PHARMACEUTICAL CO reported Cash, Period Increase (Decrease) of $6.49 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-14.

Discontinued › Notes

us-gaap:CashPeriodIncreaseDecrease · last filed 2014-11-14

  • SKYSTAR BIO-PHARMACEUTICAL CO cash, period increase (decrease) for the quarter ending 2014-09-30 was -$1.79M.
  • SKYSTAR BIO-PHARMACEUTICAL CO cash, period increase (decrease) for the quarter ending 2014-06-30 was $9.57M, a 310.30% increase year-over-year.
  • SKYSTAR BIO-PHARMACEUTICAL CO cash, period increase (decrease) for the quarter ending 2014-03-31 was -$1.29M.
  • SKYSTAR BIO-PHARMACEUTICAL CO cash, period increase (decrease) for the quarter ending 2013-12-31 was $3.69M, a 57.41% decline year-over-year.
  • SKYSTAR BIO-PHARMACEUTICAL CO cash, period increase (decrease) for fiscal 2013 was -$3.18M, a 174.41% decline from fiscal 2012.
  • SKYSTAR BIO-PHARMACEUTICAL CO cash, period increase (decrease) for fiscal 2012 was $4.27M, a 267.99% increase from fiscal 2011.
  • SKYSTAR BIO-PHARMACEUTICAL CO cash, period increase (decrease) for fiscal 2011 was $1.16M.
  • SKYSTAR BIO-PHARMACEUTICAL CO cash, period increase (decrease) for fiscal 2010 was -$5.81M.
Period endCash, Period Increase (Decrease) 3 monthCash, Period Increase (Decrease) 6 monthCash, Period Increase (Decrease) 9 monthCash, Period Increase (Decrease) 12 month
2014-09-30-$1.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14
$7.79M
derived: sum of 2 quarters · filed 2014-11-14
$6.49M
10-Q · filed 2014-11-14
$10.18M
derived: sum of 4 quarters · filed 2014-11-14
2014-06-30$9.57M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14
$8.28M
10-Q · filed 2014-08-14
$11.96M
derived: sum of 3 quarters · filed 2014-08-14
$10.11M
derived: sum of 4 quarters · filed 2014-11-14
2014-03-31-$1.29M
10-Q · filed 2014-05-15
$2.39M
derived: sum of 2 quarters · filed 2014-05-15
$536.54K
derived: sum of 3 quarters · filed 2014-11-14
$2.87M
derived: sum of 4 quarters · filed 2014-11-14
2013-12-31$3.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31
$1.83M
derived: sum of 2 quarters · filed 2014-11-14
$4.16M
derived: sum of 3 quarters · filed 2014-11-14
-$3.18M
10-K · filed 2014-03-31
2013-09-30-$1.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14
$477.13K
derived: sum of 2 quarters · filed 2014-11-14
-$6.87M
10-Q · filed 2014-11-14
$1.79M
derived: sum of 4 quarters · filed 2014-11-14
2013-06-30$2.33M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14
-$5.01M
10-Q · filed 2014-08-14
$3.64M
derived: sum of 3 quarters · filed 2014-08-14
$3.97M
derived: sum of 4 quarters · filed 2014-08-14
2013-03-31-$7.34M
10-Q · filed 2014-05-15
$1.31M
derived: sum of 2 quarters · filed 2014-05-15
$1.64M
derived: sum of 3 quarters · filed 2014-05-15
-$5.41M
derived: sum of 4 quarters · filed 2014-05-15
2012-12-31$8.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31
$8.98M
derived: sum of 2 quarters · filed 2014-03-31
$1.94M
derived: sum of 3 quarters · filed 2014-03-31
$4.27M
10-K · filed 2014-03-31
2012-09-30$326.55K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14
-$6.72M
derived: sum of 2 quarters · filed 2013-11-14
-$4.38M
10-Q · filed 2013-11-14
-$1.11M
derived: sum of 4 quarters · filed 2013-11-14
2012-06-30-$7.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
-$4.71M
10-Q · filed 2013-08-14
-$1.44M
derived: sum of 3 quarters · filed 2013-08-14
-$2.70M
derived: sum of 4 quarters · filed 2013-08-14
2012-03-31$2.34M
10-Q · filed 2013-05-15
$5.60M
derived: sum of 2 quarters · filed 2013-05-15
$4.34M
derived: sum of 3 quarters · filed 2013-05-15
$1.98M
derived: sum of 4 quarters · filed 2013-05-15
2011-12-31$3.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01
$2.00M
derived: sum of 2 quarters · filed 2013-04-01
-$354.42K
derived: sum of 3 quarters · filed 2013-04-01
$1.16M
10-K · filed 2013-04-01
2011-09-30-$1.26M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14
-$3.62M
derived: sum of 2 quarters · filed 2012-11-14
-$2.10M
10-Q · filed 2012-11-14
$1.75M
derived: sum of 4 quarters · filed 2012-11-14
2011-06-30-$2.36M
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-13
-$841.33K
10-Q/A · filed 2012-09-13
$3.01M
derived: sum of 3 quarters · filed 2012-09-13
$1.56M
derived: sum of 4 quarters · filed 2012-09-13
2011-03-31$1.52M
10-Q · filed 2012-05-15
$5.37M
derived: sum of 2 quarters · filed 2012-05-15
$3.92M
derived: sum of 3 quarters · filed 2012-05-15
2010-12-31$3.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30
$2.41M
derived: sum of 2 quarters · filed 2012-03-30
-$5.81M
10-K · filed 2012-03-30
2010-09-30-$1.45M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14
-$9.67M
10-Q · filed 2011-11-14
2010-06-30-$8.22M
10-Q/A · filed 2011-09-21